LesleyMussioArnoldMD

Psychiatry • Cincinnati, OH

Professor, Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine

Join to view full profile

Dr. Arnold is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Arnold's full profile

Already have an account?

Office
260 Stetson Avenue
Psychiatry
Cincinnati, OH 45219
Phone+1 513-558-7700

Fax+1 513-558-0877

Education & Training

University of Cincinnati Medical Center/College of MedicineResidency, Psychiatry, 1987 - 1991
Washington University/B-JH/SLCH ConsortiumInternship, Transitional Year, 1986 - 1987
University of Cincinnati College of MedicineClass of 1986

Certifications & Licensure

OH State Medical License 1990 - 2025
American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Gabapentin in Fibromyalgia Trial (GIFT) Start of enrollment: 2003 Mar 01
Completed
Phase 2, Phase 3
Double Blind Trial of Duloxetine in Chronic Fatigue Syndrome Start of enrollment: 2006 Sep 01
Completed
Phase 2, Phase 3
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome Start of enrollment: 2011 Mar 01
Completed
Phase 3
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301 Start of enrollment: 2014 Jul 01
Terminated
Not Applicable
Join now to see all

Publications & Presentations

PubMed

3 citations
Self-guided digital behavioural therapy versus active control for fibromyalgia (PROSPER-FM): a phase 3, multicentre, randomised controlled trial.
R Michael Gendreau, Lance M McCracken, David A Williams, Juan V Luciano, Yifei Dai
Lancet. 2024-07-27
6 citations
Self-guided digital acceptance and commitment therapy for fibromyalgia management: results of a randomized, active-controlled, phase II pilot clinical trial.
Stephanie Catella, R Michael Gendreau, Allison C Kraus, Nicolette Vega, Michael J Rosenbluth
Journal of Behavioral Medicine. 2024-02-01
76 citations
The Prevalence of Psychiatric and Chronic Pain Comorbidities in Fibromyalgia: an ACTTION systematic review.
Bethea A. Kleykamp, McKenzie C Ferguson, Ewan McNicol, Ida Bixho, Lesley M. Arnold
Seminars in Arthritis and Rheumatism. 2021-02-01

Press Mentions

Nerve Stimulation Therapy Could Cut Fibromyalgia PainJanuary 16th, 2020
Aptinyx Begins Two Phase 2 Studies of NYX-2925November 12th, 2019
Gabapentin Shown Effective for Fibromyalgia PainJune 12th, 2007

Grant Support

Development Of A Fibromyalgia Responder IndexNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2007–2009
Genetic Fibromyalgia StudyNational Center For Research Resources2004
Controlled Family Study In Patients With FibromyalgiaNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999–2001